# Janux Therapeutics, Inc.: Form 8-K, filed Jun 12, 2026

- Company: [Janux Therapeutics, Inc.](/companies/janx.md) (CIK 1817713)
- Form: 8-K
- Filed: 2026-06-12
- Accepted by EDGAR: Jun 12, 2026, 16:06 ET
- Period: 2026-06-11
- Accession: 0001193125-26-269387
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1817713/000119312526269387/janx-20260611.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1817713/000119312526269387/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1817713/000119312526269387/janx-20260611.htm

Filed Jun 12, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-269387. Last ingested by Listed: Nov 15, 2026, 00:55 ET. No prices; not investment advice.
